Neurology

  • Research Faculty

  • Show All

    Division Head

    A photo of Andrew D. Hershey.

    Andrew D. Hershey, MD, PhD, FAHS Director, Division of Neurology

    is interested in the characterization, molecular pathophysiology and neurophysiological, and outcome of pediatric and adolescent headache. This has extended from characterization of headache and changes across the ages and for specific headache and migraine types. The pathophysiology has included gene expression patterns of risk and response, mitochondrial cofactors and neurophysiological responses.

    513-636-4222
    andrew.hershey@cchmc.org

    Andrew D. Hershey, MD, PhD, FAHS

    Director, Division of Neurology

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-3980

    Email: andrew.hershey@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Headaches; migraines; neurogenetics; neurometabolic disorders

    Research Interests

    Epidemiology; diagnostic criteria; treatment evaluation; outcome responses; quality of life issues; pharmaceutical trials; and neurogenetics of childhood headaches

    Biography

    Andrew Hershey, MD, PhD, FAHS, received his undergraduate degree at the University of Iowa, Iowa City, Iowa. He earned an honors degree in biochemistry; his research involved the enzyme kinetic properties of alcohol dehydrogenase in yeast.

    After undergraduate school, Dr. Hershey attended the MD/PhD program at Washington University, St. Louis, Missouri. His PhD research thesis was entitled: "The Rat Substance P Receptor: cDNA and Genomic Cloning, Functional Expression, mRNA Distribution, and Mutational Analysis of Desensitization Responses."

    After earning his MD and PhD, Dr. Hershey was an intern and resident in pediatrics at St. Louis Children's Hospital, St. Louis, MO. He then was an adult neurology resident at Barnes-Jewish Hospital, St. Louis, MO, followed by his child neurology fellowship at St. Louis Children's Hospital, St. Louis, MO.

    After his fellowship, Dr. Hershey joined the faculty at Cincinnati Children's Hospital Medical Center, Ohio, where he is director of the Headache Center.

    Dr. Hershey's research interests currently include the improved diagnosis and treatment of childhood headache disorders, characterization of outcome responses, studies in new pharmacological and non-pharmacological treatment regimes, and the neurogenetics of migraines.

    Education and Training

    BS: University of Iowa, Iowa City, IA, 1985.

    MD: Washington University, St. Louis, MO, 1992.

    PhD: Washington University, St. Louis, MO, 1992.

    Residency: St. Louis Childrens Hospital, St. Louis, MO, 1993-1994; Barnes-Jewish Hospital, St. Louis, MO,1994-1995.

    Fellowship: St. Louis Childrens Hospital, St. Louis, MO, 1995-1997.

    Certification: Neurology with special competence in child neurology, 1998, recertified 2008; Headache Medicine, 2006.

    Publications

    View PubMed Publications

    Faculty

    A photo of Todd Arthur.

    Todd M. Arthur, MD Pediatric Epileptologist, Division of Neurology

    is interested in mild traumatic brain injuries (concussions) in children. It is hoped by approaching the diagnosis and treatment of concussion in a systematic manner that we can improve the quality of life and outcomes of children following mild traumatic brain injuries.

    513-636-4222
    todd.arthur@cchmc.org

    Todd M. Arthur, MD

    Pediatric Epileptologist, Division of Neurology

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Email: todd.arthur@cchmc.org

    Show All

    Specialties

    Neurophysiology in the ICU; epilepsy

    Education and Training

    MD: University of Cincinnati College of Medicine, Cincinnati, OH.

    Residency: Pediatrics, West Virginia University, Charleston; Pediatric Neurology, University of Washington.

    Fellowship: Pediatric Clinical Neurophysiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

    Certification: American Board of Pediatrics, 2002.

    Jim Collins is an Assistant Professor and Attending Physician at Cincinnati Children's.

    James (Jim) J. Collins, MD, PhD

    focuses on improving outcomes in neuromuscular disorders. He is particularly interested in individuals affected with congenital muscular dystrophy. Research focuses on the development of common data elements, outcome measures and biomarker discovery in preparation for future clinical therapeutic trials.

    513-636-4222
    james.collins@cchmc.org

    James (Jim) J. Collins, MD, PhD

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-1888

    Email: james.collins@cchmc.org

    Show All

    Specialties

    Congenital muscular dystrophies; merosin-deficient congenital muscular dystrophy

    Biography

    James Collins MD, PhD, obtained specialty training in neuromuscular disorders at the Institute of Human Genetics, Centre for Life, University of Newcastle, Newcastle, UK, in the last months of his residency training. He was then appointed assistant professor at Cincinnati Children’s Hospital Medical Center where he follows patients in general Neurology and in the Comprehensive Neuromuscular Center.

    Education and Training

    PhD: Kent State University, Kent, OH 2000.

    MD: University of Cincinnati, Cincinnati, OH 2004.

    Residency: Pediatric Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 2009.

    Certification: Child Neurology, 2009.

    Publications

    View PubMed Publications
    A photo of David Franz, MD.

    David Neal Franz, MD Director, Tuberous Sclerosis Clinic

    focuses on using a combination of clinical investigation, basic science research and innovative social programs to improve clinical care for patients with tuberous sclerosis complex (TSC). He and his team are active in human clinical trials with mTOR inhibitors to treat subependymal giant cell astrocytoma (SEGA), epilepsy and cognitive disabilities that occur in patients with TSC. In the laboratory, he is focused on understanding the mechanisms through which mTOR dysregulation in the brain contributes to TSC disease pathogenesis and developing suitable biomarkers capable of predicting disease severity and treatment response.

    513-636-4222
    franz@cchmc.org

    David Neal Franz, MD

    Director, Tuberous Sclerosis Clinic

    Associate Director of Clinical Affairs, Division of Neurology

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-1888

    Email: franz@cchmc.org

    Show All

    Specialties

    Tuberous sclerosis (adults and children); neuropharmacology; neurocutaneous disorders; general pediatric neurology

    Biography

    David Neal Franz, MD, was born and raised in Dayton, Ohio. He received his undergraduate degree in History and Literature from Earlham College in Richmond, Indiana.

    After completing his training, he served as Assistant Professor of Neurology and Pediatrics at Wright State University before returning to Cincinnati Children's Hospital Medical Center.

    He established the Cincinnati Tuberous Sclerosis Clinic in 1993, to assist in the medical care of patients who have or are suspected of having tuberous sclerosis. The purpose of the clinic is not to replace care from the child's pediatrician or family physician, but to assist the primary care physician in dealing with those aspects unique to tuberous sclerosis that affect the child's health or development. The basis of the clinic is the realization that people with tuberous sclerosis are different from other individuals who have epilepsy, learning disabilities, behavior problems, etc.

    For too long, the unique problems found in this disease have been lumped together with similar disorders, despite the fact that research has shown that disorders of the brain, heart, kidney, and other organs in tuberous sclerosis are quite different.

    Education and Training

    MD: Ohio State University College of Medicine, Columbus, OH, 1985.

    Residency: Wright State University Affiliated Hospitals, Dayton, OH. 

    Fellowship: Children's Hospital Medical Center, Cincinnati, OH. 

    Certification: Pediatrics, 1990; Neurology with special competence in child neurology, 1992.

    Publications

    View PubMed Publications
    A photo of Donald Gilbert.

    Donald L. Gilbert, MD, MS Director, Movement Disorder Clinic and Tourette's Syndrome Clinic

    is interested in motor control in children with Tourette syndrome, attention deficit hyperactivity disorder, and other conditions that affect movement. To do this, the team’s laboratory uses transcranial magnetic stimulation (TMS) to measure signals in the motor control areas of the brain and measures motor coordination in the hands. The team is also using the TMS magnet to try to improve how the brain controls speech in adults who have suffered strokes; they hope to bring this type of treatment to children in the future. The team also does trials of new medications for Tourette syndrome.
    Visit the Gilbert/Wu Lab

    513-636-4222
    donald.gilbert@cchmc.org

    Donald L. Gilbert, MD, MS

    Director, Movement Disorder Clinic and Tourette's Syndrome Clinic

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-3980

    Email: donald.gilbert@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Movement disorders; Tourette's Syndrome; Sydenham's Chorea; kernicterus; dystonia; ataxia; clinical research; transcranial magnetic stimulation

    Research Interests

    Clinical trials in Tourette's Syndrome and associated ADHD; epidemiology of Tourette's Syndrome and PANDAS; clinical effectiveness of multi-drug treatments in Tourette's Syndrome; transcranial magnetic stimulation in Tourette's Syndrome and pediatric movement disorders; functional neurosurgery for pediatric dystonia

    Visit the Gilbert-Wu Lab.

    Biography

    Donald Gilbert, MD, earned his Bachelor of Arts at Princeton University, where he majored in philosophy. He subsequently earned his MD at the University of Michigan and spent a year at the National Institutes of Health as a Howard Hughes Medical Institute Research Scholar. Dr. Gilbert did his pediatrics and neurology training at John Hopkins in Baltimore and is board certified in neurology with special competence in child neurology. Dr. Gilbert has an MS in Clinical Research Design and Statistical Analysis from the University of Michigan.

    At Cincinnati Children's, Dr. Gilbert directs the Movement Disorders and Tourette's Syndrome Clinics, which specialize in evaluation and pharmacologic treatment of tics, chorea, tremor, dystonia, stereotypies, ataxia, and other movement disorders. Dr. Gilbert directs or participates in a number of single and multi-center studies into causes and treatments of Tourette's Syndrome. Dr. Gilbert directs the Transcranial Magnetic Stimulation Laboratory at CCHMC.

    Education and Training

    BA: Princeton University, Princeton, NJ, 1987.

    MD: University of Michigan School of Medicine, Ann Arbor, MI, 1993.

    MS: University of Michigan, Ann Arbor, MI, 2003.

    Residency: Johns Hopkins School of Medicine, Baltimore, MD, 1995.

    Fellowship: Johns Hopkins School of Medicine, Baltimore, MD, 1995.

    Certification: Board Certified in Neurology with Special Competence in Child Neurology, 2010. Board eligible in Pediatrics.

    Appointment: Associate Professor of Pediatric Neurology.

    Publications

    View PubMed Publications
    A photo of Tracy Glauser.

    Tracy A. Glauser, MD Associate Director, Cincinnati Children's Research Foundation

    is the Director of the Comprehensive Epilepsy Center and co-director of the Genetic Pharmacology Service. His research has focused on improving the care of children with epilepsy through identifying the genetic and non-heritable factors that underlie the inter-individual variation in response to antiepileptic medications. Since 2003, he has directed the NIH-funded Childhood Absence Epilepsy trial, a 31-center, 446-patient double-blind randomized comparative trial of three commonly used antiepileptic medications focused on identifying the optimal initial therapy for children with childhood absence epilepsy and the pharmacokinetic, pharmacodynamic, and pharmacogenetic factors that impact the inter-individual response to antiepileptic therapy. Glauser and the Genetic Pharmacology Service (www.gps.cchmc.org) have also developed and are testing treatment selection algorithms for epilepsy and non-epilepsy medications that incorporate genetic information and drug-drug interactions.

    513-636-4222
    tracy.glauser@cchmc.org

    Tracy A. Glauser, MD

    Associate Director, Cincinnati Children's Research Foundation

    Director, Comprehensive Epilepsy Center

    Co-Director, Genetic Pharmacology Service

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-3980

    Email: tracy.glauser@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Epilepsy; pharmacogenetics; clinical pharmacology

    Research Interests

    Clinical pharmacology; pharmacogenetics; antiepileptic clinical trials 

    Biography

    Tracy A. Glauser, MD, is professor of Pediatrics, director of the Comprehensive Epilepsy Center and co-director of the Genetic Pharmacology Service at Cincinnati Children’s Hospital Medical Center. Dr. Glauser received his medical degree, cum laude, from Jefferson Medical College in Philadelphia, PA. He completed his residency in pediatrics at the John Hopkins Hospital in Baltimore, MD, and fellowship in child neurology at The Children’s Hospital of Philadelphia, University of Pennsylvania in Philadelphia, PA. Dr. Glauser completed a National Institute of Neurological Disorders and Stroke research fellowship in pediatric neurology and was a fellow in epilepsy and electroencephalography at St. Louis Children’s Hospital, Washington University School of Medicine in St. Louis, Missouri.

    Dr. Glauser has authored and co-authored more than 130 articles and book chapters, been involved with the development of 6 evidence based guidelines about epilepsy therapy and given over 150 invited lectures throughout the world. He has been the principal investigator on multiple NIH grants. Currently, Dr. Glauser directs the NIH funded Childhood Absence Epilepsy clinical trial involving 32 pediatric centers around the United States. Dr. Glauser’s fields of expertise are pediatric neurology, pediatric epilepsy, clinical pharmacology and pharmacogenetics.

    Education and Training

    MD: Jefferson Medical College, Philadelphia, PA, 1985.

    Residency: Johns Hopkins Hospital, Baltimore, MD.

    Fellowship: St. Louis Children's Hospital, St. Louis, MO.

    Certification: Pediatrics, 1990; Neurology (with special competence in child neurology), 1991.

    Publications

    View PubMed Publications

    Grants

    Sodium channel gene variation in the treatment of epilepsy. Collaborator. Apr 2009 - Mar 2014. #R01NS062756.

    The epilepsy phenome/ genome project (EPGP). Pharmacogenetics Core/Site Principal Investigator. May 2007- Apr 2012. #R01NS053998.
    A photo of Barbara Hallinan.

    Barbara E. Hallinan, MD, PhD Pediatric Neurologist

    focuses on investigating the neurochemical mechanisms responsible for the onset of epilepsy in infants, especially infantile spasms. Early diagnosis and treatment of epilepsy in this age group has the potential to improve developmental outcome. It is hoped that a better understanding of the pathogenesis of epilepsy in infants will shift the treatment paradigm from managing the clinical convulsions to correcting the underlying neurochemical pathology.

    513-636-4222

    Barbara E. Hallinan, MD, PhD

    Pediatric Neurologist

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-1888

    Show All

    Specialties

    Infantile epilepsy

    Education and Training

    PhD: Florida State University, Tallahassee, FL, 1989.

    MD: University of Cincinnati College of Medicine, Cincinnati, OH, 2001.

    Residency: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

    Certification: Pediatrics, 2007; Neurology with Special Qualification in Child Neurology, 2007.

    Publications

    View PubMed Publications
    A photo of Katherine D. Holland.

    Katherine D. Holland, MD, PhD Pediatric Epileptologist

    focuses on understanding the reasons medications fail to control seizures in certain people with epilepsy. This work includes development of clear definitions of drug response, analysis of genetic factors that predict treatment response and analyzing the neurophysiological differences between treatment responsive and treatment resistant epilepsy. The goal of this work is to predict treatment response so that care can be more individualized.


    katherine.holland@cchmc.org

    Katherine D. Holland, MD, PhD

    Pediatric Epileptologist

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Show All

    Specialties

    Mechanisms of epileptogenesis

    Education and Training

    MD: Washington University, St Louis MO, 1991.

    PhD (pharmacology): Washington University, St Louis MO, 1991.

    Internship: Children's Hospital, Boston MA.

    Residency: St Louis Children's Hospital, St Louis, MO.

    Certification: Neurology with added qualification in pediatric neurology, 2000.

    Publications

    View PubMed Publications
    A photo of Paul Horn.

    Paul S. Horn, PhD

    is a statistician who is part of the Division of Neurology.  He works on various research projects including the data analysis of epilepsy and seizures, neuromuscular conditions, mitochondrial diseases, and migraines.  His other statistical interests include robust and nonparametric methods and their application to the derivation of reference ranges.

    513-803-3256
    paul.horn@cchmc.org

    Paul S. Horn, PhD

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-803-3256

    Email: paul.horn@cchmc.org

    Show All

    Specialties

    Robustness; nonparametrics; statistical computing; simulations; reference intervals.

    Education and Training

    PhD: Statistics, Princeton University, Princeton, NJ, 1981.

    Publications

    View PubMed Publications
    No photo available

    Sejal V. Jain, MD Director, Epilepsy-Sleep Clinical Program

    is interested in the field of sleep and epilepsy and their interactions. Working on identifying prevalence of sleep disorder, screening methods and ideal treatments for sleep disorders in patients with epilepsy. The goal is also to identify the impact of treatment of sleep disorders on seizure control in these patients.

    513-636-4222
    sejal.jain@cchmc.org

    Sejal V. Jain, MD

    Director, Epilepsy-Sleep Clinical Program

    Director, Epilepsy/Clinical Neurophysiology Fellowship Program

    Pediatric Epileptologist

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-1888

    Email: sejal.jain@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Medical and surgical management of epilepsy; sleep disorders

    Research Interests

    Sleep disorders in children with epilepsy; clinical drug trials

    Biography

    Dr. Jain is a clinical researcher who is trained in pediatric epilepsy and sleep medicine. Her clinical research is focused on sleep disorders in children with epilepsy. The core of her research is to identify the best treatment options for sleep disorders in children with epilepsy and evaluate the impact on seizure control. Dr. Jain is also interested in antiepileptic drug trials.

    Dr. Jain developed and is currently directing the Epilepsy-Sleep Clinical Program. She also directs the Epilepsy/Clinical Neurophysiology Fellowship Program. She is ranked among America’s top physicians (Consumer Research Council of America, 2009-2012).

    Education and Training

    MD: Gujarat University, India.

    Residency: Nassau University Medical Center, NY.

    Fellowships: Clinical Neurophysiology and Pediatric Neurology, Virginia Commonwealth University, Richmond, Virginia; Sleep Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

    Certifications: Neurology (Child Neurology); Clinical Neurophysiology, Sleep Medicine.

    Publications

    View PubMed Publications

    Grants

    Clinical Research Feasibility Funds (CReFF). Principle Investigator. Center for Clinical and Translational Science and Training, Cincinnati Children’s Hospital Medical Center. Apr 2010 - Jul 2013.

    Clinical and Translational Science Award (CTSA). Principle Investigator. The National Center for Research Resources, NIH. Jul 2010 - Jul 2013. USPHS Grant # UL1RR026314.

    A photo of Marielle Kabbouche.

    Marielle A. Kabbouche, MD Child Neurologist

    is interested in acute treatment of intractable migraine headache including emergency room evaluation and treatment as well as inpatient therapies. The goal is not only to identify intractable headache but being able to identify short-term as well as long-term outcome to these interventions in children and adolescents.

    513-636-4222
    marielle.kabbouche@cchmc.org

    Marielle A. Kabbouche, MD

    Child Neurologist

    Academic Information

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-1888

    Email: marielle.kabbouche@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Headaches; migraines; acute and inpatient treatment of intractable headache

    Research Interests

    Headache; outcome studies; health improvement; clinical effectiveness

    Biography

    Marielle Kabbouche, MD, received her training in Child Neurology at Vanderbilt University school of medicine. She moved to Cincinnati for a specialty training in pediatric headache medicine . The position was the first for a pediatric neurologist.

    After her headache training she stayed at Cincinnati Children's as faculty and active member of the center with involvement in all academic as well as clinical and teaching aspect of pediatric headache. Since that time she has been proud to be part of the maturing center that gradually developed to be the largest and most academically productive pediatric headache program in the United States and worldwide. She has been a co- PI on multiple NIH grants since 2002 and have been involved in multiple pharmaceutical and clinical studies in pediatric and adolescent migraine.

    Her carrier has been focused on acute treatment of intractable Migraine in Children in emergency room as well as inpatient settings.

    As the Director of the inpatient headache unit, Dr. Kabbouche was actively involved in setting an acute headache infusion center as well as an inpatient headache unit at Cincinnati Children’s Hospital Medical Center. The Headache acute care unit has been very productive in the last few years and seeing about 200-300 patients/year during peak seasons. The inpatient unit will open in July of 2011 bringing specialty care to the headache patients with a team of 6 providers , fellows , residents and nurses. This approach to intractable headache care will have a great impact on patient’s outcome.

    Dr. Kabbouche has over 25 publications, and a track record of numerous peer-reviewed papers, reviews, and abstracts in the field of headache medicine, book chapters as well as being an editor of a pediatric headache book.

    Education and Training

    MD: Saint Joseph University, Faculty of Medicine, Beirut, Lebanon.

    Residency: Vanderbilt University Medical Center, Nashville, TN.

    Fellowship: Cincinnati Children's Hospital, Cincinnati, OH.

    Publications

    View PubMed Publications

    Grants

    Acute treatment of headaches in children and adolescents. Co-Principal Investigator. American Headache Society. 2007 - 2012.

    Drug & Non-Drug Treatment of Pediatric Chronic Headache. Co-Investigator. National Institute of Neurological Disorders and Stroke. 2006 - 2011. #R01 NS050536-01A1.

    A photo of Darren Kadis.

    Darren S. Kadis, PhD

    studies brain-behavior relationships using modern neuroimaging techniques (i.e., MRI, MEG, etc.). His research is directed at understanding the typical organization of the brain, the role of early experience on brain structure and functional representation, and the vulnerability and plasticity of the brain in the context of early neurological insult.

    513-636-2577
    darren.kadis@cchmc.org

    Darren S. Kadis, PhD

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-2577

    Email: darren.kadis@cchmc.org

    Show All

    Specialties

    Neuroimaging; epilepsy; language

    Biography

    Dr. Kadis received his PhD through the Department of Psychology at the University of Toronto, with a distinction in Neuroscience and training in Clinical Neuropsychology. He conducted his graduate and post-doctoral research at the Hospital for Sick Children in Toronto, gaining experience with invasive (i.e., intracarotid sodium amobarbital procedure, electrocortical stimulation mapping) and newer noninvasive (e.g., fMRI, MEG) brain mapping procedures. His research is directed at understanding the typical organization of the brain, the role of early experience on brain structure and functional representation, and the vulnerability and plasticity of the brain in the context of early neurological insult. Currently, Dr. Kadis uses MEG in concert with structural neuroimaging and neuropsychological procedures to study speech and language representation and plasticity in the brains of children.

    Education and Training

    PhD: University of Toronto, ON, Canada, 2010.

    Publications

    View PubMed Publications
    A photo of Darcy Krueger.

    Darcy A. Krueger, MD, PhD Associate Director of Research, Division of Neurology

    uses a combination of clinical investigation, basic science research and innovative social programs to improve clinical care for patients with tuberous sclerosis complex (TSC). We are active in human clinical trials with mTOR inhibitors to treat subependymal giant cell astrocytoma (SEGA), epilepsy and cognitive disabilities that occur in patients with TSC. In the laboratory, we are focused on understanding the mechanisms through which mTOR dysregulation in the brain contributes to TSC disease pathogenesis and developing suitable biomarkers capable of predicting disease severity and treatment response.

    513-636-4222
    krueger_darcy@cchmc.org

    Darcy A. Krueger, MD, PhD

    Associate Director of Research, Division of Neurology

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Email: krueger_darcy@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Tuberous sclerosis; general neurology

    Research Interests

    Tuberous sclerosis; clinical use of mTOR inhibitors; role of mTOR pathway in neurological disease

    Education and Training

    MD: Saint Louis University School of Medicine, St. Louis, Missouri, 1995-1997; 2000-2002.

    PhD: Saint Louis University Graduate School Biochemistry and Molecular Biology, St. Louis, Missouri, 1997-2000.

    Publications

    View PubMed Publications
    A photo of Michael Miles.

    Michael V. Miles, PharmD Director, Neuropharmacology Laboratory

    focuses on development and validation of novel laboratory tests and biomarkers for monitoring mitochondrial function and oxidative stress; promoting collaborative research involving mitochondrial abnormalities associated with aging, obesity, neuromuscular diseases, epilepsy, sleep apnea and nutritional deficiencies; and evaluating the safety and efficacy of new antioxidant formulations, such as coenzyme Q and vitamin E.

    513-636-7871
    michael.miles@cchmc.org

    Michael V. Miles, PharmD

    Director, Neuropharmacology Laboratory

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-636-7871

    Fax: 513-636-1888

    Email: michael.miles@cchmc.org

    Show All

    Specialties

    Pediatric pharmacology; laboratory tests and biomarkers for monitoring mitochondrial function and oxidative stress; mitochondrial abnormalities associated with aging, obesity, sleep apnea, epilepsy and nutritional deficiencies; safety and efficacy of treatment with antioxidants, such as coenzyme Q and vitamin E.

    Biography

    Michael V. Miles, PharmD, has been a member of the Division of Pediatric Neurology for over 5 years. He is an experienced clinician and researcher, who has studied the pharmacokinetics and pharmacodynamics of drugs in pediatric populations for much of his career. He has dedicated his clinical and research efforts to improving the efficacy and safety of drug therapy for infants and children. His research is currently focused on the development of new biomarkers and therapeutic agents for patients with mitochondrial diseases.

    Education and Training

    PharmD: University of Texas at Austin, Austin, Texas, 1979.

    Specialty Residency: Pediatric Clinical Pharmacy, University of Texas at Austin, Austin, Texas.

    Certification: Pharmacy, 1976.

    Publications

    View PubMed Publications
    A photo of Diego Morita, MD.

    Diego A. Morita, MD Co-Director, New Onset Seizure Clinic

    513-636-4222
    diego.morita@cchmc.org

    Diego A. Morita, MD

    Co-Director, New Onset Seizure Clinic

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-1888

    Email: diego.morita@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Epilepsy; therapeutic drug management; pharmacogenetics

    Research Interests

    Clinical pharmacology; population pharmacokinetics; antiepileptic drug tolerability

    Biography

    Dr. Morita obtained his Medical Degree with honors from the University of Buenos Aires School of Medicine in Buenos Aires, Argentina. He finished a three-year residency in Pediatrics at Buenos Aires British Hospital in Buenos Aires, Argentina. In 1996, he came to the United States and continued his training in Pediatrics at Miami Children's Hospital in Miami, Florida.

    Dr. Morita was then a resident in Neurology at the University of Cincinnati, and later a fellow in Child Neurology at Cincinnati Children's. He completed fellowship training in Clinical Neurophysiology and Epilepsy, and Epilepsy Clinical Neuropharmacology, both at Cincinnati Children's.

    After his fellowships, Dr. Morita opened a Child Neurology private practice in Buenos Aires, Argentina, and in 2005 returned and joined the faculty at Cincinnati Children's.

    Dr. Morita's interests currently include the objective assessment of antiepileptic drug side effects, pharmacogenetics of antiepileptic drugs, and individualization of drug therapy.

    Education and Training

    MD: University of Buenos Aires, Buenos Aires, Argentina, 1992.

    Residency: Buenos Aires British Hospital, Buenos Aires, Argentina; Miami Children's Hospital, Miami, FL; University of Cincinnati, Cincinnati, OH.

    Fellowship: Child Neurology: Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Clinical Neurophysiology and Epilepsy: Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Epilepsy Clinical Neuropharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

    Publications

    View PubMed Publications
    A photo of Hope O'Brien.

    Hope L. O'Brien, MD Director, Young Adult Headache Program, Division of Neurology

    is an adult neurologist, interested in the transition stages of chronic headache as one develops from childhood into adults, with focus on the unique aspects of headaches and its impact on late adolescents and young adults. This includes identifying modifiable features in children with migraine that will result in reduction of intractable cases as one develops.

    513-636-4222
    neurodesk@cchmc.org

    Hope L. O'Brien, MD

    Director, Young Adult Headache Program, Division of Neurology

    Director, Headache Medicine Fellowship

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-1888

    Email: neurodesk@cchmc.org

    Show All

    Specialties

    Headache

    A photo of Douglas Rose, MD.

    Douglas F. Rose, MD Pediatric Epileptologist

    is interested in clinical neurophysiology of normal and abnormal brain function across multiple neuropsychiatric disorders using multiple modalities, principally electroencephalography (EEG), magnetoencephalography (MEG) and functional magnetic resonance imaging (fMRI). The normal brain function includes developmental vision, hearing, touch perception, spontaneous motor movement, attention, memory, language and pain perception. The neuropsychiatric disorders include epilepsy, cerebral palsy, stroke, tic disorders, obsessive-compulsive disorder and traumatic brain injury.

    513-636-4222
    douglas.rose@cchmc.org

    Douglas F. Rose, MD

    Pediatric Epileptologist

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-3980

    Email: douglas.rose@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Epilepsy; improvement of the quality of life for children with epilepsy; studies of brain and physiology to better understand brain function

    Research Interests

    Neuropharmacology; epilepsy surgery; central auditory processing; magnetoencephalography; functional cortical mapping; fMRI; SPECT; vagus nerve stimulator; ketogenic diet; language development and language disorders

    Biography

    Dr. Rose grew up in Cleveland, Ohio. He and his wife lived briefly in Fairborn and Dayton, Ohio when first married. Subsequently they moved to Washington, DC to study and work at the National Institutes of Health. They then moved to Albuquerque, New Mexico for several years to continue work and research, before moving to Memphis, Tennessee and then Cincinnati.

    Education and Training

    MD: Case Western Reserve University, Cleveland, Ohio, 1977

    Residency: Rainbow Babies and Childrens, Cleveland, Ohio, 1979

    Fellowship: University Hospitals, Cleveland, Ohio, 1982

    Instructor:, Department of Neurology, University Hospitals, Cleveland, Ohio, 1983

    Fellowship: Epilepsy, National Institutes of Health, Bethesda, Md., 1983-1984

    Fellowship: Neurophysiology, National Institutes of Health, Bethesda, Md., 1984-1985

    Medical Staff Fellow: Clinical Epilepsy Section, National Institutes of Health, 1983-1984

    Medical Staff Fellow: EEG Laboratory, National Institutes of Health, 1984-1986

    Medical Staff Fellow: Unit on Neurophysiology, National Institutes of Health, 1986-1987

    Senior Staff Fellow: Unit on Neurophysiology, National Institutes of Health, 1987-1989

    Associate Professor: Department of Neurology, University of New Mexico, Albuquerque, N.M., 1989-1992

    Director: Center for Magnetoencephalography, Albuquerque, N.M., 1989-1992

    Associate Professor: Department of Pediatrics, University of Tennessee, Memphis, Tenn. 1992-2000

    Associate Professor: Department of Neurology, University of Tennessee, Memphis, Tenn. 1992-2000

    Adjunct Associate Professor: Memphis Speech and Hearing Center, Department of Audiology, University of Memphis, Tenn., 1998-present.

    Division Chief: Child Neurology, Department of Pediatrics, University of Tennessee, 1994-2000

    Medical Director: Comprehensive Epilepsy Center, Le Bonheur Children's Medical, Center, Memphis, Tenn., 1992-2000

    Director: Cincinnati Children's Neurodiagnostic Laboratory, 2003 to present.

    Director: Cincinnati Children's Clinical Neurophysiology Fellowship Program, 2001 to present.

    Medical Director: Cincinnati Children's MEG Center, 2005 to present.

    Certification: Pediatrics 1984 ; Neurology with special competence in Child Neurology 1984; Clinical Neurophysiology 1986; Added Qualifications in Clinical Neurophysiology 1994

    Practice Locations: Cincinnati Children's Hospital Medical Center Main Campus; Outpatient Services -- Anderson

    A photo of Mark Schapiro.

    Mark Schapiro, MD

    is interested in identifying specific biomarkers for future neurological deficits, which may also serve as therapeutic targets in neonatal care. For example, premature newborns are at high risk for later neurological disorders due to disruption of normal brain development by prematurity, in association with ischemic and inflammatory injury in utero or in the perinatal period.

    513-636-4222
    mark.schapiro@cchmc.org

    Mark Schapiro, MD

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-3980

    Email: mark.schapiro@cchmc.org

    Show All

    Specialties

    Genetic and hormonal determinants of brain function; aging of the nervous system in developmental disorders

    Education and Training

    MD: University of Tennessee, Memphis, Tenn. 1976.

    Residency: Pediatric Neurology, Boston City Hospital, Boston, Mass., 1980-1983.

    Fellowship: National Institute on Aging, 1983-1989.

    Certification: Pediatrics, 1985; Neurology and Psychiatry.

    A photo of Matthew Skelton.

    Matthew R. Skelton, PhD

    is a neuroscientist who has a basic research program on the role of creatine in brain structure and function. The primary focus of his lab is the study of the mechanisms underlying intellectual disability caused by mutations in the creatine transporter gene.


    matthew.skelton@cchmc.org

    Matthew R. Skelton, PhD

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Show All

    Education and Training

    BA: Biology, Bellarmine University, Louisville, KY, 2000.

    PhD: Molecular and Developmental Biology, University of Cincinnati, Cincinnati, OH, 2006.

    Publications

    View PubMed Publications
    No photo available

    Shannon M. Standridge, MPH, DO

    is interested in the specific field of pediatric neurology, focusing on cost effective analyses. She seeks to understand the significance of healthcare savings and the magnitude of improvement in quality of life over an expected lifetime in young children undergoing epilepsy surgery.

    513-636-4222
    neurodesk@cchmc.org

    Shannon M. Standridge, MPH, DO

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-1888

    Email: neurodesk@cchmc.org

    Show All

    Specialties

    General neurology

    Education and Training

    Fellowship: Neurophysiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2008; Neurology, Nationwide Children's Hospital, Columbus, OH, 2007.

    Residency: Pediatrics, Nationwide Children's Hospital, Columbus, OH, 2004.

    MPH: The Ohio State University College of Public Health, Columbus, OH, 2008.

    DO: Kansas City University of Medicine and Biosciences, Kansas City, MO, 2002.

    BS: Biology, Lyon College, Batesville, AS, 1997.

    Publications

    View PubMed Publications
    A photo of Mary Sutton.

    Mary Sutton, MD

    513-636-4222

    Mary Sutton, MD

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-3980

    Show All

    Specialties

    Neuro-oncology

    Education and Training

    MD: University of Rochester School of Medicine and Dentistry, Rochester, NY, 1989.

    Residency: Pediatrics, Children's Hospital, Boston, MA.

    Fellowship: Neurology, Children's Hospital, Boston, MA.

    Certification: Pediatrics, 1996; Neurology, 1996.

    A photo of Cameron Thomas.

    Cameron Thomas, MD, MS

    is interested in understanding the effects of early life events such as seizures, medical procedures and pain on the developing brain.  

    513-636-4222
    cameron.thomas@cchmc.org

    Cameron Thomas, MD, MS

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Email: cameron.thomas@cchmc.org

    Show All

    Education and Training

    MD: University of Colorado Health Sciences Center, Denver, CO, 2005.

    Residency: Child Neurology, Cincinnati Children’s Hospital, Cincinnati, OH.

    Certification: Neurology with Special Qualification in Child Neurology, 2010.

    MS: Clinical and Translational Research, University of Cincinnati, Cincinnati, OH, 2013.

    Publications

    A photo of Jennifer Vannest.

    Jennifer J. Vannest, PhD

    is interested in the use of functional MRI and behavioral testing to examine how epilepsy and neurodevelopmental disorders affect language function and the brain circuitry that supports it. The goal of these studies is to provide better treatment and educational strategies for children with these disorders.

    513-636-6959
    jennifer.vannest@cchmc.org

    Jennifer J. Vannest, PhD

    Academic Information

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-6959

    Email: jennifer.vannest@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Cognitive neuroscience of language and memory (using functional MRI); cognitive effects of epilepsy and neurodevelopmental disorders

    Research Interests

    Neurological disorders and language impairments

    Biography

    Jennifer Vannest, PhD, completed her undergraduate education at the Ohio State University and continued there for her graduate work. Her PhD is in linguistics, and in addition, her graduate training included a number of courses in cognitive psychology, neuropsychology and speech and hearing sciences. As a postdoctoral fellow at University of Michigan and University of Rochester, Dr. Vannest was trained to use functional MRI to study the brain mechanisms underlying language skill.

    Dr. Vannest came to Cincinnati Children's Hospital Medical Center in 2006, and her current research makes use of functional MRI to examine how epilepsy and neurodevelopmental disorders affect language function, ultimately leading to better treatment and educational strategies for children with these disorders.

    Education and Training

    PhD: Ohio State University, Linguistics.

    Postdoctoral Training: University of Michigan (Psychology), University of Rochester (Brain and Cognitive Sciences).

    Publications

    View PubMed Publications
    A photo of Charles Vorhees.

    Charles V. Vorhees, PhD

    focuses on how drugs, genes, immune activators and environmental agents adversely affect the developing brain, along with Dr. Michael Williams. Projects range from early stress to prenatal exposure to drugs of abuse, from creatine transporter deficiency to genes associated with depression, and from lead-manganese toxicity to autism. The overarching interest is on developmental origins of nervous system disorders, particularly those originating prenatally using behavioral, neurochemical, immunohistochemical, pharmacological and genetic methods.
    Visit the Vorhees/Williams Lab.

    513-636-8622
    charles.vorhees@cchmc.org

    Charles V. Vorhees, PhD

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-636-8622

    Fax: 513-636-3912

    Email: charles.vorhees@cchmc.org

    Show All

    Specialties

    Principal areas of investigation are how drugs, genetic mutations, environmental agents, and stressors affect prenatal and neonatal brain development and behavior.  The lab is particularly interested in the long-term effects of such perturbations on cognitive development.

    Visit the Vorhees-Williams-Skelton Lab.

    Biography

    Dr. Vorhees came to Cincinnati Children’s in 1976 as a postdoctoral research scholar and was recruited to the faculty in 1978 as assistant professor. He was promoted to associate professor in 1982, tenured in 1984, and promoted to professor in 1988 with primary appointment in pediatrics and joint appointment in environmental health. He is co-director of the Animal Behavior Core and program director of the Teratology Training Program.  He is on the graduate faculty of the Graduate Programs in Neuroscience (NS) and Molecular and Developmental Biology (MDB). He is section editor of the journal Neurotoxicology and Teratology and served as editor-in-chief for nine years. He was director of the MDB Graduate Program for six years and served in other leadership positions for 15 years. Dr. Vorhees has also served in leadership positions in the NS Program and is currently a member of the Admissions Committee. Dr. Vorhees has been extramurally funded for 35 years, receiving grants from NIH, NSF, FDA and other agencies. He holds an NIH T32 training grant funded for years 36-40 through 2017.  He is a founding member of the Neurobehavioral Teratology Society in 1977 and was elected president in 1984-85 and 2012-13.  He is an elected member of Sigma Xi, an Eli Lilly Distinguished Lecturer in 1990, and a Society for Neuroscience Grass Foundation Lecturer in 2002.  Dr. Vorhees has served on multiple FDA, NRC, and EPA advisory panels.  He has been an NIH grant reviewer on varies committees for more than 26 years.  He has also reviewed grants for NSF, VA, EPA; March of Dimes, and other agencies and foundations in the U.S.; and for funding agencies in Israel, Ireland, Great Britain, and New Zealand.  His research focuses on brain development and behavior.  As of 2013 he has published than more 276 journal articles and book chapters.

    Visit the Vorhees Lab Site

    Visit the Animal Behavioral Core Site

    Education and Training

    MA: Neurobiology Program, Vanderbilt University, Nashville, TN, 1973.

    PhD: Neurobiology Program, Vanderbilt University, Nashville, TN, 1976.

    Publications

    View PubMed Publications

    Grants

    Selective disruption of hippocampal dentate granule cells in autism: impact of PTEN deletion. Co-Investigator, National Institutes of Health. 2009-2014

    Acute neurotoxicity of pyrethroids. Principal Investigator. CAPHRA. 2012-2014.

    Prenatal SSRI Exposure and ASD. Principal Investigator. Congressionally Directed Medical Research Program, Department of Defense. 2013-2015.

    Latrophilin-3 and ADHD: A new potential mechanism. Principal Investigator. National Institutes of Health.  2013-2015.

    Training Grant in Teratology. Principal Investigator. National Institutes of Health. 2012-2017.

    A photo of Anna Weber Byars.

    Anna Weber Byars, PhD, ABPP-Cn Pediatric Neuropsychologist

    is focused on neuropsychological and behavioral aspects of epilepsy. She also collaborates with researchers in the Imaging Research Center on studies of cognitive development as well as clinicians conducting clinical trials in genetic diseases.

    513-636-4222

    Anna Weber Byars, PhD, ABPP-Cn

    Pediatric Neuropsychologist

    Academic Information

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-3980

    Show All

    Specialties

    Functional MRI; stroke; epilepsy; language disorders

    Education and Training

    PhD: University of Alabama at Birmingham, Birmingham, AL.

    Internship: West Virginia University School of Medicine, Morgantown, WV.

    Fellowship: Pediatric Neuropsychology, Children's Hospital Medical Center, Cincinnati, OH.

    A photo of Kris Wesselkamper.

    Kris R. Wesselkamper, MD Pediatric Neurologist

    is interested in including quality improvement, safety and standardization of care for patients with neurologic conditions who are admitted to the hospital.

    513-636-4222
    kris.wesselkamper@cchmc.org

    Kris R. Wesselkamper, MD

    Pediatric Neurologist

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-1888

    Email: kris.wesselkamper@cchmc.org

    Show All

    Education and Training

    MD: University of Cincinnati, Cincinnati, OH, 2000.

    Pediatric Residency: MetroHealth Medical Center, Cleveland, OH, 2000-2003.

    Child Neurology Residency: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2003-2006.

    Board Certification: Neurology with Special Qualification in Child Neurology, American Board of Psychiatry and Neurology, 2007.

    A photo of Michael Williams.

    Michael T. Williams, PhD

    focuses on how drugs, genes, immune activators and environmental agents adversely affect the developing brain, along with Dr. Charles Vorhees. Projects range from early stress to prenatal exposure to drugs of abuse, from creatine transporter deficiency to genes associated with depression, and from lead-manganese toxicity to autism. The overarching interest is on developmental origins of nervous system disorders, particularly those originating prenatally using behavioral, neurochemical, immunohistochemical, pharmacological and genetic methods.
    Visit the Vorhees/Williams/Skelton Lab.

    513-636-4222
    michael.williams@cchmc.org

    Michael T. Williams, PhD

    Academic Information

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-1888

    Email: michael.williams@cchmc.org

    Show All

    Specialties

    Education and Training

    AA: Psychology, Belleville Area College.

    BS: Psychology, Wright State University.

    PhD: Biomedical Sciences, Wright State University.

    Postdoctoral Fellow: Psychoneuroimmunology, Ohio State University.

    Postdoctoral Fellow: Teratology, Children's Hospital Research Foundation.

    Publications

    View PubMed Publications
    A photo of Jonathan Wilson.

    Jonathan A. Wilson, PhD

    investigates the role and development of real-time, bedside analysis of neurological data in epilepsy and traumatic brain injury.

    513-803-4758
    jonathan.wilson@cchmc.org

    Jonathan A. Wilson, PhD

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-803-4758

    Email: jonathan.wilson@cchmc.org

    Show All

    Specialties

    Clinical

    Epilepsy; traumatic brain injury

    Research

    Brain-computer interfaces

    Education and Training

    PhD: Biomedical Engineering, University of Wisconsin, Madison, WI.

    BS: Electrical and Computer Engineering, The Ohio State University, Columbus, OH.

    Publications

    A photo of Brenda Wong.

    Brenda Wong, MD, MBBS Professor of Clinical Pediatrics and Neurology, Director of Comprehensive Neuromuscular Center

    focuses on neuromuscular disorders in children including clinical research in Duchenne muscular dystrophy and spinal muscular atrophy and genomics in DMD and NM disorders.

    513-636-4222
    brenda.wong@cchmc.org

    Brenda Wong, MD, MBBS

    Professor of Clinical Pediatrics and Neurology, Director of Comprehensive Neuromuscular Center

    Academic Information

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-3980

    Email: brenda.wong@cchmc.org

    Show All

    Specialties

    Neuromuscular disorders

    Biography

    After medical school, Brenda Wong, MD, received training in General Pediatrics and worked as a pediatrician for a few years before doing her three-year Child Neurology fellowship at Children's Hospital Medical Center, Cincinnati.

    Dr. Wong also received training in Pediatric Neuromuscular Disorders at Hammersmith Hospital, London with Dr. Victor Dubowitz and Dr. Francesco Muntoni. Dr. Wong's training in EMGs was accomplished with Dr. John Quinlan at Department of Neurology, University of Cincinnati.

    Post fellowship training, Dr. Wong was practicing child neurology in private practice prior to joining Children's Hospital Medical Center of Cincinnati in 1999.

    Besides general neurology patients, Dr. Wong sees patients with neuromuscular disorders in the Neuromuscular Clinic and provide diagnostic services like EMGs and evaluation for muscle biopsies. Comprehensive management is supported by the Department of Rehabilitative Medicine, Pulmonary Medicine, Pediatric Orthopedics and the Muscular Dystrophy Association.

    Education and Training

    MD: University of Singapore, 1980.

    Residency: University Department of Pediatrics, Singapore, 1981, 1984-85, Royal Hospital for Sick Children, Edinburgh 1985-88.

    Fellowship: Child Neurology, Children's Hospital Medical Center, Cincinnati, OH, 1994-97; Neuromuscular Disorders, Hammersmith Hospital, London, 1997.

    Certification: Child Neurology, 1998.

    Publications

    View PubMed Publications

    Grants

    A photo of Steve Wu.

    Steve W. Wu, MD

    is interested in pediatric movement disorders, including Tourette syndrome. He is also actively involved in transcranial magnetic stimulation research.
    Visit the Gilbert/Wu Lab

    513-636-4222

    Steve W. Wu, MD

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Show All

    Specialties

    Neuroplasticity; movement disorders; transcranial magnetic stimulation; transcranial magnetic stimulation lab

    Visit the Gilbert-Wu Lab.

    Biography

    Dr. Steve Wu is a pediatric neurologist with interests in children with movement disorders. His research interest focuses on movement disorders and neuroplasticity of the brain. Dr. Wu collaborates with Dr. Donald Gilbert in the Transcranial Magnetic Stimulation Lab at Cincinnati Children’s Hospital Medical Center.

    Education and Training

    BA: University of California, Berkeley CA, 1997.

    MD: Vanderbilt University, Nashville TN, 2003.

    Residency: Pediatrics and Pediatric Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati OH, 2003-2008.

    Fellowship: Pediatric Movement Disorders, Cincinnati Children’s Hospital Medical Center, Cincinnnati OH, 2008-2009.

    Publications

    A photo of Jiang Xiang.

    Jing Xiang, MD, PhD Director of MEG Research

    focuses on the identification of pathological HFBS in epilepsy, migraine and other brain disorders. Dr. Xiang is currently building on recent discoveries that the brain generates high-frequency brain signals (HFBS, ~2,632 Hz) and that magnetoencephalography (MEG) can detect HFBS noninvasively.
    Visit the Xiang Lab.

    513-636-4222
    jing.xiang@cchmc.org

    Jing Xiang, MD, PhD

    Director of MEG Research

    Academic Information

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-1888

    Email: jing.xiang@cchmc.org

    Show All

    Specialties

    Epilepsy and pre-operative functional mapping

    Visit the Xiang Lab.

    Education and Training

    MD: Postgraduate Medical School, Beijing, China, 1994.

    PhD: The Graduate University for Advanced Studies, Okazaki, Japan, 1998.

    Publications

    View PubMed Publications